EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Trypanosoma cruzi Secreted Cyclophilin TcCyP19 as an Early Marker for Trypanocidal Treatment Efficiency

Alina E Perrone iD, Mariana Pinillo, Marcela S Rial iD, Marisa Fernández iD, Natalia Milduberger, Carolina González, Patricia L Bustos, Laura E Fichera, Susana A Laucella, María Cecilia Albareda, Jacqueline Bua iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms241511875 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Alina E Perrone und 10 weiteren Autor:innen. Beteiligte Einrichtung: Instituto Nacional de Parasitología Dr. Mario Fatala Chaben-ANLIS-Malbrán, Av. Paseo Colón 568, Buenos Aires 1063, Argentina. Hauptthemen laut MEDLINE: Trypanosoma cruzi, Chagas Disease, Trypanocidal Agents, Cyclophilins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Anlis Carlos G Malbrán, Scientific and Technological Research Fund (FONCyT), Argentina, Fondos Concursables de la ANLIS Carlos G. Malbrán 2015, IP A. Perrone.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cyclophilins (CyPs) are a family of enzymes involved in protein folding. Trypanosoma cruzi, the causative agent of Chagas disease, has a 19-kDa cyclophilin, TcCyP19, that was found to be secreted in parasite stages of the CL Brener clone and recognized by sera from T. cruzi-infected mice and patients. The levels of specific antibodies against TcCyP19 in T. cruzi-infected mice and subjects before and after drug treatment were measured by an in-house enzyme linked immunosorbent assay (ELISA). Mice in the acute and chronic phase of infection, with successful trypanocidal treatments, showed significantly lower anti-TcCyP19 antibody levels than untreated mice. In children and adults chronically infected with T. cruzi, a significant decrease in the anti-TcCyP19 titers was observed after 12 months of etiological treatment. This decrease was maintained in adult chronic patients followed-up 30–38 months post-treatment. These results encourage further studies on TcCyP19 as an early biomarker of trypanocidal treatment efficiency.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Trypanosoma cruziChagas DiseaseTrypanocidal AgentsCyclophilinsProtozoan ProteinsAnimalsHumansMiceBiomarkersAdultFemaleMaleChildAntibodies, ProtozoanMiddle Aged

Stichwörter der Autor:innen

ChagasELISATcCyP19Trypanosoma cruzibenznidazolebiomarkercyclophilinnifurtimoxparasiticidal treatment

Substanzen

Trypanocidal AgentsCyclophilinsBiomarkersAntibodies, ProtozoanProtozoan Proteins

Autor:innen und Institutionen

  • Instituto Nacional de Parasitología Dr. Mario Fatala Chaben-ANLIS-Malbrán, Av. Paseo Colón 568, Buenos Aires 1063, Argentina.
  • Consejo Nacional de Investigaciones Científicas y Técnicas, Buenos Aires 1063, Argentina.

ORCID-Profile: Alina E Perrone, Marcela S Rial, Marisa Fernández, Jacqueline Bua

Förderung

  • Anlis Carlos G Malbrán
  • Scientific and Technological Research Fund (FONCyT), Argentina
  • Fondos Concursables de la ANLIS Carlos G. Malbrán 2015, IP A. Perrone

Zitieren

APA

Perrone, A. E., Pinillo, M., Rial, M. S., Fernández, M., Milduberger, N., González, C., Bustos, P. L., Fichera, L. E., Laucella, S. A., Albareda, M. C., & Bua, J. (2023). Trypanosoma cruzi Secreted Cyclophilin TcCyP19 as an Early Marker for Trypanocidal Treatment Efficiency. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241511875

Vancouver

Perrone AE, Pinillo M, Rial MS, Fernández M, Milduberger N, González C, et al. Trypanosoma cruzi Secreted Cyclophilin TcCyP19 as an Early Marker for Trypanocidal Treatment Efficiency. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241511875

BibTeX
@article{Perrone2023,
  author = {Perrone, Alina E and Pinillo, Mariana and Rial, Marcela S and Fernández, Marisa and Milduberger, Natalia and González, Carolina and Bustos, Patricia L and Fichera, Laura E and Laucella, Susana A and Albareda, María Cecilia and Bua, Jacqueline},
  title = {Trypanosoma cruzi Secreted Cyclophilin TcCyP19 as an Early Marker for Trypanocidal Treatment Efficiency},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms241511875}
}
Kostenlos starten →